Communication

Since its inception in 2008, Hypatia has been at the forefront of advancing scientific, technological, and human resources within the region. As a non-profit organization, our primary goal is to promote, develop, and enhance various fields, including materials science, biomedical devices, environmental sustainability, and renewable energy technologies. Our Mission:At Hypatia, we are driven by a […]

Company Overview: Cellex (Cell Expansion Devices) Founded in early 2018, Cellex is a forward-thinking company dedicated to pioneering advancements in the Life Sciences, Biomedical, and Biotechnology sectors. Our core mission revolves around the design, development, and production of cutting-edge mechanical, chemical, and biological devices tailored to meet the evolving needs of our clients. Mission Statement:At

Company Overview: 7hc 7hc is a pioneering Italian start-up specializing in revolutionizing drug development processes through advanced computational platforms. Our primary focus lies in creating a sophisticated service that supports the rational design, screening, and optimization of specific binders for protein targets. We aim to set a new standard for the design, development, and optimization

On April 4th and 5th, the LINKS Foundation in Turin hosted the inaugural OsteoNET workshop, a groundbreaking event that brought together experts and enthusiasts from various disciplines to delve into the latest advancements in bone health research. The workshop featured five engaging round table discussions, three on the first day and two on the second,

Consorzio di ricerca Hypatia is pleased to organize the first workshop of the European project 𝗢𝗦𝗧𝗘𝗢𝗡𝗘𝗧, which marks the beginning of a quest to weave a multidisciplinary nexus within the realm of bone technology research. The workshop will be held on 𝟰-𝟱 𝗔𝗽𝗿𝗶𝗹 𝟮𝟬𝟮𝟰 at the LINKS Foundation during the ” 𝙎𝙥𝙧𝙞𝙣𝙜 𝙤𝙛 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣” conference organized by

At the heart of OSTEONET’s groundbreaking journey are our esteemed partners, each bringing unique strengths and expertise to the forefront of bone health research. Together, we’re forging a path towards unprecedented advancements in the field. Let’s introduce our diverse and dynamic team: Each partner represents a vital piece of the OSTEONET puzzle, working in harmony to

We’re thrilled to dive deep into the heart of OSTEONET’s ambitions with our first specific objective: crafting 3D cryopreserved constructs that closely replicate the natural properties of both healthy and aging bone tissue. By leveraging cutting-edge bioengineering, we’re developing advanced 3D models that go beyond traditional research methods. These constructs are not just simulations; they’re

OSTEONET will develop cutting-edge 3D in vitro models of bone tissue. These models will mimic the complexity of human bone more accurately than ever before, paving the way for breakthroughs in how we study, diagnose, and treat bone diseases. This innovative approach is not just about enhancing research capabilities; it’s about creating a future where

Excited to launch OSTEONET, our pioneering project set to revolutionize bone disease research. Supported by the Marie Skłodowska-Curie Actions, OSTEONET aims to advance our understanding and treatment of bone-related conditions. Stay tuned for updates on our journey towards a healthier future. This visual aims to encapsulate the innovative spirit of OSTEONET research, combining elements of